Advanced search
Publication Cover
Infection and Drug Resistance Volume 15, 2022 - Issue
Submit an article Journal homepage
497
Views
15
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Ceftazidime-Avibactam versus Colistin for the Treatment of Infections Due to Carbapenem-Resistant Enterobacterales: A Multicenter Cohort Study

Thamer A Almangour1 Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, 11451, Saudi ArabiaCorrespondence[email protected]
View further author information
,
Leen Ghonem2 Clinical Pharmacy Services, King Saud University Medical City, King Saud University, Riyadh, Saudi ArabiaView further author information
,
Ahmad Aljabri2 Clinical Pharmacy Services, King Saud University Medical City, King Saud University, Riyadh, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0002-0528-9507View further author information
ORCID Icon,
Alya Alruwaili3 Infectious Diseases Services, King Fahad Medical City, Riyadh, Saudi ArabiaView further author information
,
Mohammed Al Musawa4 Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi ArabiaView further author information
,
Nader Damfu5 Pharmaceutical Care Department, King Abdul Aziz Medical City, Jeddah, Saudi ArabiaView further author information
,
Mesfer S Almalki6 Pharmaceutical Services, Security Forces Hospital, Makkah, Saudi ArabiaView further author information
,
Majda Alattas4 Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi ArabiaView further author information
,
Hossam Abed4 Pharmaceutical Care Division, King Faisal Specialist Hospital & Research Centre, Jeddah, Saudi ArabiaView further author information
,
Doaa Naeem5 Pharmaceutical Care Department, King Abdul Aziz Medical City, Jeddah, Saudi ArabiaView further author information
,
Nawaf Almalki5 Pharmaceutical Care Department, King Abdul Aziz Medical City, Jeddah, Saudi ArabiaView further author information
&
Abdullah A Alhifany7 Department of Clinical Pharmacy, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi ArabiaORCID Iconhttps://orcid.org/0000-0001-9492-9483View further author information
ORCID Icon show all
Pages 211-221 | Published online: 23 Jan 2022

Citations (15)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Haiyang Meng, Yongmei Zhao, Qi An, Baoling Zhu, Zhe Cao & Jingli Lu. (2023) Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study. Infection and Drug Resistance 16, pages 5815-5824.
Read now
Abdul Haseeb, Zikria Saleem, Ummara Altaf, Narjis Batool, Brian Godman, Umar Ahsan, Mehreen Ashiq, Mutiba Razzaq, Rabia Hanif, Zill E-Huma, Afreenish Amir, Mohammad Akbar Hossain, Mohamed Raafat, Rozan Mohammad Radwan, Muhammad Shahid Iqbal & Sairah Hafeez Kamran. (2023) Impact of Positive Culture Reports of E. coli or MSSA on De-Escalation of Antibiotic Use in a Teaching Hospital in Pakistan and the Implications. Infection and Drug Resistance 16, pages 77-86.
Read now
Peng Liu, Yumiao Mai, Wenhua Yuan, Lei Xie, Wei Ma, Jian Liu, Lu Xu, Jing Yang, Peile Wang & Huaili Wang. (2022) Risk Factors for Mortality and Antimicrobial Regimens in Pediatric Intensive Care Unit Patients with Carbapenem-Resistant Enterobacteriaceae Infections: A Six-Year Retrospective Study. Infection and Drug Resistance 15, pages 7307-7316.
Read now
Daniele Roberto Giacobbe, Jason A. Roberts, Mohd H. Abdul-Aziz, Etienne de Montmollin, Jean-François Timsit & Matteo Bassetti. (2022) Treatment of ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacteria with novel agents: a contemporary, multidisciplinary ESGCIP perspective. Expert Review of Anti-infective Therapy 20:7, pages 963-979.
Read now

Articles from other publishers (11)

Ping Yang, Yinyan Li, Xiaojuan Wang, Na Chen & Xiaoyang Lu. (2023) Efficacy and safety of ceftazidime–avibactam versus polymyxins in the treatment of carbapenem-resistant Enterobacteriaceae infection: a systematic review and meta-analysis. BMJ Open 13:5, pages e070491.
Crossref
Khalil Chaïbi, Françoise Jaureguy, Hermann Do Rego, Pablo Ruiz, Céline Mory, Najoua El Helali, Sara Mrabet, Assaf Mizrahi, Jean-Ralph Zahar & Benoît Pilmis. (2023) What to Do with the New Antibiotics?. Antibiotics 12:4, pages 654.
Crossref
Kazi Sarjana Safain, Mohammad Sazzadul Islam, Jumanah Amatullah, Mohammad Al Mahmud-Un-Nabi, Golam Sarower Bhuyan, Jakia Rahman, Suprovath Kumar Sarker, Md Tarikul Islam, Rosy Sultana, Firdausi Qadri & Kaiissar Mannoor. (2023) Prevalence of silver resistance determinants and extended-spectrum β-lactamases in bacterial species causing wound infection: First report from Bangladesh. New Microbes and New Infections 52, pages 101104.
Crossref
Zikria Saleem, Abdul Haseeb, Brian Godman, Narjis Batool, Ummara Altaf, Umar Ahsan, Faiz Ullah Khan, Zia Ul Mustafa, Muhammad Umer Nadeem, Muhammad Junaid Farrukh, Muhammad Mugheera, Inaam Ur Rehman, Asma Fareed Khan, Hamid Saeed, Mohammad Akbar Hossain, Mohamed Raafat, Rozan Mohammad Radwan & Muhammad Shahid Iqbal. (2022) Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications. Antibiotics 12:1, pages 70.
Crossref
Ahmad Alharbi, Attiah Khobrani, Afnan Noor, Waad Alghamdi, Abdulmalik Alotaibi, Mohammed Alnuhait & Abdul Haseeb. (2022) Risk of Lichen Sclerosus and Lichen Planus in Patients Receiving Immune Checkpoint Inhibitors. International Journal of Environmental Research and Public Health 20:1, pages 580.
Crossref
C. J. Kelley, A. Kennedy-Mendez, O. N. Walser, M. T. Thwaites, F. F. Arhin, C. M. Pillar & D. A. Hufnagel. (2022) Evaluation of Dilution Susceptibility Testing Methods for Aztreonam in Combination with Avibactam against Enterobacterales. Microbiology Spectrum 10:6.
Crossref
Usman Abubakar, Amni Izzati Zulkarnain, Jesús Rodríguez-Baño, Norhidayah Kamarudin, Mahmoud E. Elrggal, Mohamed Hassan Elnaem & Sabariah Noor Harun. (2022) Treatments and Predictors of Mortality for Carbapenem-Resistant Gram-Negative Bacilli Infections in Malaysia: A Retrospective Cohort Study. Tropical Medicine and Infectious Disease 7:12, pages 415.
Crossref
Samuel Windham & Marin H. Kollef. (2022) How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections?. Current Opinion in Infectious Diseases 35:6, pages 561-567.
Crossref
Sisi Zhen, Hui Wang & Sizhou Feng. (2022) Update of clinical application in ceftazidime–avibactam for multidrug-resistant Gram-negative bacteria infections. Infection 50:6, pages 1409-1423.
Crossref
Hajar Alqahtani, Ahlam Alghamdi, Nouf Alobaidallah, Amal Alfayez, Rawan Almousa, Rawan Albagli, Nour Shamas, Fayssal Farahat, Ebrahim Mahmoud, Mohammad Bosaeed & Reem Abanamy. (2022) Evaluation of ceftazidime/avibactam for treatment of carbapenemase-producing carbapenem-resistant Enterobacterales with OXA-48 and/or NDM genes with or without combination therapy. JAC-Antimicrobial Resistance 4:5.
Crossref
Ili Margalit, Virginie Prendki, Ori Tishler, Marco Falcone, Giusy Tiseo, Yaara Leibovici-Weissman, Mical Paul & Dafna Yahav. (2022) Effectiveness and safety of colistin among older adults: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy 77:8, pages 2094-2104.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.